How Technology is Transforming Venture Capital Portfolio Management in the Modern Era

In the fast-paced world of venture capital, staying ahead of the curve is essential for success. With the rapid advancements...

Investing in startups has always been an exciting and potentially lucrative venture. However, traditionally, this type of investment was limited...

Investing in startups has always been an exciting and potentially lucrative venture. However, traditionally, this type of investment was limited...

Investing in startups has always been an exciting and potentially lucrative venture. However, traditionally, this type of investment was limited...

Private equity deals in the alternative assets space have been making headlines in recent months, with a flurry of activity...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private equity deals in AltAssets for October 31, 2023 have been making waves in the private equity sector. With a...

Private Equity Deals in Review: AltAssets Private Equity Deal Roundup for October 31, 2023 As we bid farewell to October,...

Private equity deals in the alternative assets (AltAssets) sector have been making headlines recently, with a flurry of activity taking...

Private equity deals are a crucial aspect of the financial world, with investors constantly on the lookout for lucrative opportunities...

Private equity deals have been a hot topic in the financial world, with investors eagerly watching for the latest developments...

Private equity deals in AltAssets have been making headlines recently, with several notable transactions taking place in the industry. As...

Flashpoint, a leading direct secondaries firm, is looking to expand its presence in the European market with a new $150...

Flashpoint, a leading private equity firm, is looking to expand its presence in the European direct secondaries market with a...

Flashpoint, a leading global private equity firm, has set its sights on increasing European direct secondaries deals with a new...

Flashpoint, a leading global private equity firm, is making waves in the European direct secondaries market with its new fund...

Flashpoint, a leading private equity firm, has recently announced the launch of a new fundraising initiative aimed at targeting European...

Flashpoint, a leading private equity firm, is looking to expand its presence in the European direct secondaries market with a...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private Equity Deals in Review: AltAssets Private Equity Deal Roundup for October 31, 2023 As we bid farewell to October,...

Private Equity Deals in Review: AltAssets Private Equity Deal Roundup for October 31, 2023 As we bid farewell to October,...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private Equity Deals in Review: AltAssets Private Equity Roundup for October 31, 2023 As we bid farewell to October 2023,...

Private equity deals in alternative assets, also known as AltAssets, have been gaining momentum in recent years as investors seek...

DexCare secures $75M funding to expand its care access platform.

DexCare, a Seattle-based healthcare technology company, has recently secured $75 million in funding to expand its care access platform. The funding round was led by Brighton Park Capital and included participation from Kaiser Permanente Ventures, Define Ventures, and Frist Cressey Ventures.

DexCare’s platform is designed to help healthcare organizations optimize their appointment scheduling and patient access processes. The platform uses advanced analytics and machine learning algorithms to match patients with the right provider at the right time, based on their specific needs and preferences.

The company’s technology is particularly useful for large healthcare systems that have multiple clinics and providers, as it can help to streamline the appointment booking process and reduce wait times for patients. By improving access to care, DexCare aims to improve patient outcomes and reduce healthcare costs.

With the new funding, DexCare plans to expand its platform to more healthcare organizations across the United States. The company also plans to invest in new technology and talent to further enhance its platform and improve patient access to care.

“We’re thrilled to have the support of such a strong group of investors as we continue to grow and scale our platform,” said Gaurav Bhattacharya, CEO of DexCare. “Our mission is to make it easier for patients to access the care they need, when they need it, and this funding will help us bring that vision to even more healthcare organizations.”

The COVID-19 pandemic has highlighted the importance of telehealth and virtual care, and DexCare’s platform is well-positioned to help healthcare organizations adapt to these changes. By providing patients with more options for accessing care, including virtual visits and in-person appointments, DexCare can help to improve patient satisfaction and reduce the burden on healthcare providers.

Overall, DexCare’s $75 million funding round is a significant milestone for the company and a positive development for the healthcare industry as a whole. By improving patient access to care, DexCare is helping to drive better health outcomes and reduce healthcare costs, which is a win-win for patients, providers, and payers alike.